Frequency of CYP1A1*2A and GSTM1 gene polymorphisms in Chilean patients with squamous cell carcinoma of the larynx in relation to smoking habit: a pilot study
Main Article Content
Keywords
Carcinoma ofthe larynx, xenobiotics, CYP1A1, GSTM1, gene polymorphisms
Abstract
Introduction: Tobacco and alcohol consumption are recognized risk factors for squamous cell carcinoma of the larynx. These xenobiotics are metabolized by numerous enzymes, among which, CYP1A1 and GSTM1 gene polymorphisms have been identified as risk factors for developing tobacco related cancers as lung and laryngeal carcinomas. Nevertheless, these polymorphisms have not been studied in Chilean patients with squamous cell carcinoma of the larynx. Aim: To describe, for the first time, the frequency of CYP1A1 and GSTM1 gene polymorphisms in Chilean patients with squamous cell carcinoma of the larynx. Material and method: We conducted a case-control study. The case group consisted of 35 Chilean patients with squamous cell carcinoma of the larynx; the control group was formed by 124 Chilean subjects without cancer diagnosis. Demographic data as age, sex and quantification of tobacco smoking and alcohol consumption were recorded in all individuals. CYP1A1 and GSTM1 gene polymorphisms were evaluated by polymerase chain reaction and restriction enzymes (PCR-RFLP). Results: The frequency of CYP1A1*2A C/C genotype was 54, 3% among laryngeal cancer patients and 17, 1% among control subjects. The frequency of GSTM1 (-/-) genotype was 19, 35 % among laryngeal cancer patients and 10, 48% among control subjects.There were no statistically significant relationships between this gene polymorphisms and tobacco smoking or alcohol consumption. There were no associations between the presence of both gene polymorphisms in the same individual and the presence of laryngeal cancer. Interestingly we found an OR of 8.69 (CI 2.90 to 26.01) for GSTM1 (-/-) polymorphism and laryngeal cancer, stratified by tobacco smoking and alcohol consumption. Conclusions: Our work shows that the deletion of GSTM1 could be an important risk factor for squamous cell carcinoma of the larynx in Chilean patients. This finding reflects the important role that detoxification of carcinogenic compounds plays in Chilean population. However, it is necessary to increase the number of studied patients to properly establish the genetic-environmental relationship ascribed to these biomarkers.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
El envío de un manuscrito supone que los autores declaran ser titulares originarios y exclusivos de los derechos de autoría sobre el artículo, de conformidad a lo dispuesto en la ley 17.336 sobre Propiedad Intelectual en Chile.
La Revista de Otorrinolaringología y Cirugía de Cabeza y Cuello da acceso libre (Open Access) a su contenido.
Esta obra está bajo una licencia Creative Commons CC BY 4.0. Esta licencia permite el uso de los contenidos, pero no permite un uso comercial de la obra original, y el artículo puede ser modificado y distribuido, pero bajo la misma licencia que el material original. Además, permite a terceros utilizar el contenido publicado siempre que hagan referencia a su publicación en esta revista.
La Revista de Otorrinolaringología y Cirugía de Cabeza y Cuello no realiza cargos por acceder a los artículos publicados ni se realizan cobros a los autores por la recepción y publicación de artículos.